SB
ACAD icon

Suntrust Banks’s Acadia Pharmaceuticals ACAD Stock Holding History

Suntrust Banks’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,400
Closed -$226K – 1257
2015
Q2 		$226K Buy
+5,400
New +$209K ﹤0.01% 1125
2014
Q3 		– Sell
-10,527
Closed -$236K – 1372
2014
Q2 		$236K Sell
10,527
-1,003
-9% -$20.9K ﹤0.01% 1304
2014
Q1 		$280K Buy
11,530
+92
+0.8% +$2.33K ﹤0.01% 1618
2013
Q4 		$284K Buy
11,438
+35
+0.3% +$826 ﹤0.01% 1543
2013
Q3 		$312K Buy
+11,403
New +$238K ﹤0.01% 1465

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Suntrust Banks's ACAD Position: Q3 2015 in Review

Suntrust Banks sold out of Acadia Pharmaceuticals (ACAD) in Q3 2015, closing a stake of 5,400 shares — an estimated $226K sold.

Suntrust Banks first reported a position in ACAD in Q3 2013 and held it in 5 quarters. The position peaked at $312K in Q3 2013. 188 funds tracked by Wall St. Rank hold ACAD as of Q3 2015.

  • Suntrust Banks reported no remaining Acadia Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Suntrust Banks sold 5,400 Acadia Pharmaceuticals shares in Q3 2015, an estimated $226K.
  • Suntrust Banks first reported a position in Acadia Pharmaceuticals in Q3 2013 and held it in 5 quarters.
  • Suntrust Banks's Acadia Pharmaceuticals position peaked at $312K in Q3 2013.
  • 188 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2015.

Based on Suntrust Banks's 13F filing for Q3 2015, filed 16 Nov 2015.